Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Richardson

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
JAMA Otolaryngology-- Head & Neck Surgery|May 30, 2024
Genetic Risk For Depression and Quality of Life in Patients With Head and Neck CancerMelissa Henry, Lawrence M Chen, Laurence Ducharme, et al.
Head & Neck|March 11, 2026
Toward a Typology of Patients With Head and Neck Cancer: Biopsychosocial Profiles Predicting Longitudinal Quality of LifeHaley Deamond, Cyril Devault-Tousignant, Jacob Lang, et al.
Molecular & Cellular Proteomics : MCP|August 10, 2014
Ion mobility tandem mass spectrometry enhances performance of bottom-up proteomicsDominic Helm, Johannes P C Vissers, Christopher J Hughes, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Biopsychosocial Markers of Body Image Concerns in Patients with Head and Neck Cancer: A Prospective Longitudinal StudyJustine G Albert, Christopher Lo, Zeev Rosberger, et al.
Journal of Affective Disorders|March 22, 2023
Genetic predisposition to depression and inflammation impacts symptom burden and survival in patients with head and neck cancer: A longitudinal studyMelissa Henry, Raphaële Harvey, Lawrence M Chen, et al.
Cell Reports|March 2, 2025
The NF1 tumor suppressor regulates PD-L1 and immune evasion in melanomaDiana Berry, Dan Moldoveanu, Shivshankari Rajkumar, et al.
The Lancet. Oncology|August 17, 2019
Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trialAnthony C Nichols, Julie Theurer, Eitan Prisman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2024
Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Final Results of the ORATOR Randomized TrialAnthony C Nichols, Julie Theurer, Eitan Prisman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2022
Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR TrialAnthony C Nichols, Julie Theurer, Eitan Prisman, et al.
Mass Spectrometry Reviews|February 2, 2019
Recommendations for reporting ion mobility Mass Spectrometry measurementsValérie Gabelica, Alexandre A Shvartsburg, Carlos Afonso, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
JAMA Otolaryngology-- Head & Neck Surgery|May 30, 2024
Genetic Risk For Depression and Quality of Life in Patients With Head and Neck CancerMelissa Henry, Lawrence M Chen, Laurence Ducharme, et al.
Head & Neck|March 11, 2026
Toward a Typology of Patients With Head and Neck Cancer: Biopsychosocial Profiles Predicting Longitudinal Quality of LifeHaley Deamond, Cyril Devault-Tousignant, Jacob Lang, et al.
Molecular & Cellular Proteomics : MCP|August 10, 2014
Ion mobility tandem mass spectrometry enhances performance of bottom-up proteomicsDominic Helm, Johannes P C Vissers, Christopher J Hughes, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Biopsychosocial Markers of Body Image Concerns in Patients with Head and Neck Cancer: A Prospective Longitudinal StudyJustine G Albert, Christopher Lo, Zeev Rosberger, et al.
Journal of Affective Disorders|March 22, 2023
Genetic predisposition to depression and inflammation impacts symptom burden and survival in patients with head and neck cancer: A longitudinal studyMelissa Henry, Raphaële Harvey, Lawrence M Chen, et al.
Cell Reports|March 2, 2025
The NF1 tumor suppressor regulates PD-L1 and immune evasion in melanomaDiana Berry, Dan Moldoveanu, Shivshankari Rajkumar, et al.
The Lancet. Oncology|August 17, 2019
Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trialAnthony C Nichols, Julie Theurer, Eitan Prisman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2024
Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Final Results of the ORATOR Randomized TrialAnthony C Nichols, Julie Theurer, Eitan Prisman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2022
Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR TrialAnthony C Nichols, Julie Theurer, Eitan Prisman, et al.
Mass Spectrometry Reviews|February 2, 2019
Recommendations for reporting ion mobility Mass Spectrometry measurementsValérie Gabelica, Alexandre A Shvartsburg, Carlos Afonso, et al.
Pageof 10